Biotech · Private company
Mirror Biologics, Inc.
Track this companyFree. Adds Mirror Biologics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- AlloStimPhase 2 · Virus DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- AlloStimPhase 2 · Colorectal Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- AlloStimPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- AlloStimPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- AlloStim-8Phase 2 · Advanced or Refractory Leukemia, Lymphoma, Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- BavencioPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- CryoablationPhase 2 · Colorectal Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- CryoablationPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal CancerPHASE2 · WITHDRAWN · started Nov 1, 2026ClinicalTrials.gov NCT06557278 · fetched Nov 12, 2026
- Immunotherapy for Third Line Metastatic Colorectal CancerPHASE2 · COMPLETED · started Jul 12, 2021ClinicalTrials.gov NCT04444622 · fetched Nov 12, 2026
- Universal Anti-Viral Vaccine for Healthy Elderly AdultsPHASE1_PHASE2 · COMPLETED · started Jul 12, 2021ClinicalTrials.gov NCT04441047 · fetched Nov 12, 2026
- AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal CancerPHASE2 · COMPLETED · started Sep 1, 2016ClinicalTrials.gov NCT02380443 · fetched Nov 12, 2026
- Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer PatientsPHASE1_PHASE2 · WITHDRAWN · started Mar 1, 2014ClinicalTrials.gov NCT02018419 · fetched Nov 12, 2026
- Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood CancersPHASE1_PHASE2 · TERMINATED · started Jan 1, 2010ClinicalTrials.gov NCT00861965 · fetched Nov 12, 2026